Journal
JOURNAL OF CHEMOTHERAPY
Volume 15, Issue 3, Pages 290-292Publisher
E I F T SRL
DOI: 10.1179/joc.2003.15.3.290
Keywords
vincristine; hearing loss; toxicity; peripheral T-cell lymphoma
Ask authors/readers for more resources
Vincristine sulfate is a chemotherapeutic agent used in different cancer therapies. It is also the first choice of treatment for peripheral T-cell lymphoma with cyclophosphamide and adriamycin. Sudden hearing loss during vincristine therapy is a very rare event. This is a case of a 16-year old girl who developed sudden bilateral hearing loss related to vincristine therapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
